Does synbiotic supplementation affect the quality of life in children with cystic fibrosis? A pilot randomized controlled clinical trial
Does synbiotic supplementation affect the quality of life in children with cystic fibrosis? A pilot randomized controlled clinical trial
نویسندگان: نعمت بیلان , زینب نیک نیاز , لیلا نیک نیاز , مهدیه عباسعلیزاد فرهنگی
کلمات کلیدی: Quality of life, Cystic fibrosis, Synbiotic, Children
نشریه: 0 , 44 , 6 , 2020
| نویسنده ثبت کننده مقاله |
زینب نیک نیاز |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
بیماری های گوارش و کبد |
| کد مقاله |
75676 |
| عنوان فارسی مقاله |
Does synbiotic supplementation affect the quality of life in children with cystic fibrosis? A pilot randomized controlled clinical trial |
| عنوان لاتین مقاله |
Does synbiotic supplementation affect the quality of life in children with cystic fibrosis? A pilot randomized controlled clinical trial |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
BMC nutrition |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background: There is no clinical trial that assesses the effect synbiotic supplementation on HRQOL in CF children.
Considering the importance of HRQOL as an essential primary outcome and determinant of therapeutic benefit in
chronic diseases like cystic fibrosis, the present clinical trial aimed to determine the efficacy of synbiotic
supplementation on HRQOL in children with CF.
Methods: In the present double-blind randomized clinical trial, 40 CF children were randomly allocated to the two
groups. The intervention group was supplemented with synbiotics supplements and the patients in the placebo
group received maltodextrin for 6 months. Demographic data and information about antibiotic use were recorded
using the questionnaire. The health-related quality of life was assessed using the Persian version of quality of life
inventory questionnaires. Paired t-test and ANCOVA were used for statistical analysis.
Results: Totally, 36 participants completed the trial. The mean score of HRQOL was 76.34 ± 17.33. There were no
significant differences between synbiotic and placebo groups regarding baseline demographic and quality of life
characteristics. Compared with baseline values, the mean total score and subscores of quality of life did not change
significantly after synbiotic and placebo supplementation (p > 0.05). Moreover, the results of ANCOVA showed that
there were no significant differences between the two groups regarding the post-trial value of HRQOL total score
and subscores.
Conclusion: According to results, six-month supplementation with synbiotic did not have a significant effect on
the HRQOL in children with CF. However, further studies with larger sample sizes and using more disease-specific
questionnaires are needed for a more precise conclusion.
The protocol of the study was registered at Iranian registry clinical trials (Registration code: IRCT2017011732004N1;
Registration date: 2017-02-14). |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 40795_2020_Article_373.pdf | 1400/01/31 | 377643 | دانلود |